Simple, speedy, sensitive, and specific serodiagnosis of pertussis by using a particle agglutination test

Journal of Clinical Microbiology

Volumn 35, Issue 7, 1997, Pages 1859-1861

  Aoyama, Tatsuo ^a,b   Kato, Tatsuo ^c   Takeuchi, Yoshinao ^a   Kato, Kazuaki ^d   Morokuma, Kazunori ^e   Hirai, Takenori ^e  

^a KAWASAKI MUNICIPAL HOSPITAL   (Japan)

^b KEIO UNIVERSITY   (Japan)

^c ST MARIANNA UNIVERSITY   (Japan)

^d Imperial Foundation Saiseikai Utsunomiya Hospital   (Japan)

^e Chemo Sero Therapeutic Research Institute   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

PERTUSSIS TOXIN; PERTUSSIS VACCINE; POLY(GAMMA METHYLGLUTAMIC ACID); POLYMER; TOXIN ANTIBODY; UNCLASSIFIED DRUG;

AGGLUTINATION TEST; ANTIBODY TITER; ARTICLE; BORDETELLA PERTUSSIS; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; INFANT; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; PERTUSSIS; PRIORITY JOURNAL; SERODIAGNOSIS;

EID: 0030990021     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/jcm.35.7.1859-1861.1997     Document Type: Article

References (11)

1. Ad Hoc Group for the Study of Pertussis Vaccines. 1988. Placebo-controlled trial of two acellular pertussis vaccines in Sweden: protective efficacy and adverse event. Lancet i:955-960.
2. Granström, G., B. Wretlind, C. R. Salenstedt, and M. Granström. 1988. Evaluation of serologic assays for diagnosis of whooping cough. J. Clin. Microbiol. 26:1818-1823.
3. Granström, M., G. Granstrom, P. Gillenius, and P. Askelof. 1985. Neutralizing antibodies to pertussis toxin in whooping cough. J. Infect. Dis. 151:646-649.
4. Hallander, H., J. Storsaeter, and R. Möllby. 1991. Evaluation of serology and nasopharyngeal cultures for diagnosis of pertussis in a vaccine efficacy trial. J. Infect. Dis. 163:1046-1054.
5. Hirayama, C., H. Ihara, M. Shibata, T. Hirai, T. Fujiyasu, and Y. Yamauchi. 1991. Polypeptide artificial carrier particles for use in passive agglutination immunoassay. Polymer J. 23:161-165.
6. Ihara, H., T. Yoshinaga, and C. Hirayama. 1986. Preparation and gel permeation chromatographic properties of porous spheres from poly (γ-methyl or γ-benzyl L-glutamate). J. Chromatogr. 362:197-207.
7. Manclark, C. R., B. D. Meade, and D. G. Burstyn. 1986. Serological response to Bordetella pertussis, p. 388-394. In N. R. Rose, H. Friedman, and J. L. Fahey (ed.), Manual of clinical laboratory immunology, 3rd ed. American Society for Microbiology, Washington, D.C.
8. Meade, B. D., A. Deforest, K. M. Edwards, T. A. Romani, F. Lynn, C. H. O'Brien, C. B. Swartz, G. F. Reed, and M. A. Deloria. 1995. Description and evaluation of serologic assays used in a multicentcr trial of acellular pertussis vaccines. Pediatrics 96:570-575.
9. Robinson, A., and L. A. E. Ashworth. 1988. Acellular and defined-component vaccines against pertussis, p. 399-417. In A. C. Wardlaw and R. Parton (ed.), Pathogenesis and immunity in pertussis. John Wiley & Sons Ltd., London, United Kingdom.
10. Thomas, M. G., L. A. E. Ashworth, E. Miller, and H. P. Lambert. 1989. Serum IgG, IgA, and IgM responses to pertussis toxin, filamentous hemagglutinin, and agglutinogens 2 and 3 after infection with Bordetella pertussis and immunization with whole-cell pertussis vaccine. J. Infect. Dis. 160:838-845.
11. Watanabe, M., Y. Nakase, T. Aoyama, H. Ozawa, Y. Murase, and T. Iwata. 1986. Serotype and drug susceptibility of Bordetella pertussis isolated in Japan from 1975 to 1984. Microbiol. Immunol. 30:491-494.